Article Details
Retrieved on: 2023-11-21 18:32:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In a deal worth up to $610 million, Merck will gain a pipeline of neuroscience and rare disease programs from a startup it previously backed.
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here